Management of Focal Lytic Lesion in Left Iliac Bone with Sclerotic Foci

Immediate Priority: Referral to Specialized Center

The European Society for Medical Oncology recommends that all patients with suspected primary malignant bone tumors must be referred to a bone sarcoma reference center or specialized bone sarcoma network before biopsy, as bone sarcomas are frequently difficult to recognize as malignant by clinicians, radiologists, and pathologists 1, 2, 3
The National Comprehensive Cancer Network suggests that the 16 x 9.9 mm lytic lesion with sclerotic margin in the left iliac bone requires tissue diagnosis to exclude malignancy, particularly given it was noted on prior imaging and warrants correlation with clinical history 1, 3

The American College of Radiology recommends documenting duration, intensity, and timing of any bone pain, particularly night pain, as part of the clinical history 1, 2, 3
The European Society for Medical Oncology suggests identifying any prior benign/malignant lesions, family history of bone tumors, or previous radiotherapy exposure as part of the clinical history 1, 2, 3
The National Comprehensive Cancer Network recommends determining patient age, as differential diagnosis varies: after 40 years of age, metastasis or myeloma become more likely than primary bone sarcoma 2, 3

The American College of Surgeons recommends examining for size and consistency of any palpable swelling as part of the physical examination 1, 2, 3
The European Society for Medical Oncology suggests assessing mobility and relation of any swelling to the involved bone as part of the physical examination 1, 2, 3

The National Comprehensive Cancer Network recommends that MRI of the pelvis with adjacent joints is the best modality for local staging of pelvic tumors and should be performed if not already done 2, 3
The American College of Radiology suggests that CT may be used to better visualize calcification, periosteal bone formation, cortical destruction, or soft tissue involvement if diagnostic uncertainty remains 2, 3

The European Society for Medical Oncology recommends that the biopsy must be performed at the reference center by the surgeon who will carry out definitive tumor resection or by a radiologist member of that team 1, 2, 3
The National Comprehensive Cancer Network suggests that core needle biopsies under imaging control are appropriate and minimize contamination of normal tissues 2, 3

The American College of Radiology recommends considering metastatic disease (most common in adults over 40 years) as a differential diagnosis for the lytic lesion with sclerotic margin 2, 3
The European Society for Medical Oncology suggests considering multiple myeloma (common after age 40) as a differential diagnosis for the lytic lesion with sclerotic margin 2, 3
The National Comprehensive Cancer Network recommends considering primary bone sarcoma (chondrosarcoma, osteosarcoma, Ewing sarcoma) as a differential diagnosis for the lytic lesion with sclerotic margin 1, 2

The American College of Radiology recommends considering bone islands/enostoses (for the sclerotic foci) as a differential diagnosis for the lytic lesion with sclerotic margin 1
The European Society for Medical Oncology suggests considering infection/osteomyelitis as a differential diagnosis for the lytic lesion with sclerotic margin 2, 3

The National Comprehensive Cancer Network recommends never performing biopsy outside a specialized bone sarcoma center, as improper biopsy technique can contaminate tissues and compromise limb-salvage surgery 1, 2, 3
The European Society for Medical Oncology suggests not assuming the lesion is benign based solely on the sclerotic margin; tissue diagnosis is mandatory 1, 2, 3

The American College of Radiology recommends bone scintigraphy and chest CT to assess for distant disease if malignancy is confirmed 1
The National Comprehensive Cancer Network suggests that small pulmonary nodules on CT are not specific for malignancy and may require additional evaluation 1